Skip to content

Author

Sun-Hyang Park

We have 3 of 103 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Anti-TIM-4 Monoclonal Antibody Treatment Reduces Autoreactive CD8+ T Cells and Restores Euglycemia in New-Onset Diabetic NOD Mice

Anti-TIM-4 monoclonal antibody treatment markedly reduced IGRP206–214-reactive CD8+ T-cell frequencies in pancreatic lymph nodes and pancreas compared with untreated diabetic mice and was associated with preservation of pancreatic islet architecture.

Yoon-Ju Kim, Y. Jeon, Se-Hyun Oh et al. · 0 citations
Open access Aug 2026

Rationale and design of the EXCELSIOR-CKD trial: intensive blood pressure and lipid control in advanced chronic kidney disease.

As the first randomized trial to determine whether intensive SBP and LDL-C lowering improve kidney outcomes in advanced CKD, this study could help define optimal targets and inform future guideline recommendations.

Yaerim Kim, Jwa-Kyung Kim, Gang-Jee Ko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.